Torts Blog

GlaxoSmithKline has agreed to settle yet another big group of product-liability lawsuits involving one of its popular meds. The latest deal ...

In light of the Johnson & Johnson recall scandal, the House Committee on Oversight & Government Reform has, as promised, introduced ...

Here are the headlines and links to several stories on Avandia since the recent reports on the FDA panel recommendation to keep it on the ma...

From a story in Pharmalot: Another day, another large settlement. Rather than ring up tabs for expensive lawyers and confront the possibili...

A few days ago, I reported that an FDA penal surprisingly voted to keep the diabetes drug Avandia on the market. In separate stories, it has...

Here is a link to a story in AboutLawsuits on the vote to keep Avandia on the market.

Just as an FDA panel was meeting to determine whether to recommend to withdraw Avandia from the market, Bloomberg News , Pharmalot and Abou...

After years of debate, mountains of data, harsh opinions, corporate intrigue and agency infighting, the FDA advisory committee voted to 20-1...

A few days ago, I posted that it appears increasingly likely that an FDA advisory panel will recommend to take Avandia off the market after ...

A couple of weeks ago, the Blog of the Legal Times reported that, despite opposition from the business community, the Senate appears ready t...